Silverarc Capital Management, Llc Portfolio Stock Holdings
According to the SEC 13F filed on August 13, 2026, Silverarc Capital Management, Llc disclosed 61 stock positions valued at approximately $898.52M as of quarter-end June 30, 2026. The largest holdings include CELCUITY INC, COGENT BIOSCIENCES INC, and IMMUNOME INC.
- Report Period
- June 30, 2026
- No. of Stocks
- 61
- Portfolio Value
- $898.52M
Holdings by Sector
Silverarc Capital Management, Llc Portfolio Holdings in Q2 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| CELCUITY INC | CELC | Healthcare | 5.83% | 500,996 | +143,093 | +39.98% | $52,414,202 |
| COGENT BIOSCIENCES INC | COGT | Healthcare | 5.52% | 1,280,707 | -33,482 | -2.55% | $49,563,361 |
| IMMUNOME INC | IMNM | Healthcare | 4.76% | 2,017,009 | +166,731 | +9.01% | $42,740,421 |
| DIANTHUS THERAPEUTICS INC | DNTH | Healthcare | 4.23% | 390,000 | -264,746 | -40.43% | $38,017,200 |
| RHYTHM PHARMACEUTICALS INC | RYTM | Healthcare | 3.85% | 311,461 | +5,461 | +1.78% | $34,581,515 |
| ORUKA THERAPEUTICS INC | ORKA | Other | 3.74% | 352,802 | +201,894 | +133.79% | $33,576,166 |
| MONTE ROSA THERAPEUTICS INC | GLUE | Healthcare | 2.98% | 1,108,295 | -893,745 | -44.64% | $26,820,739 |
| SYNDAX PHARMACEUTICALS INC | SNDX | Healthcare | 2.95% | 1,214,390 | +325,403 | +36.60% | $26,546,565 |
| ENLIVEN THERAPEUTICS INC | ELVN | Healthcare | 2.76% | 489,382 | +489,382 | +100.00% | $24,836,137 |
| IMMUNOVANT INC | IMVT | Healthcare | 2.65% | 619,096 | +204,860 | +49.45% | $23,853,769 |
| ERASCA INC | ERAS | Healthcare | 2.58% | 1,263,026 | -588,786 | -31.80% | $23,138,636 |
| SAGIMET BIOSCIENCES INC | SGMT | Healthcare | 2.52% | 2,927,698 | +2,927,698 | +100.00% | $22,631,106 |
| ABIVAX SA | ABVX | Healthcare | 2.52% | 169,593 | -132,937 | -43.94% | $22,599,963 |
| PRAXIS PRECISION MEDICINES I | PRAX | Healthcare | 2.45% | 65,679 | -5,873 | -8.21% | $21,988,672 |
| KODIAK SCIENCES INC | KOD | Healthcare | 2.37% | 546,256 | -445,674 | -44.93% | $21,282,134 |
| DEFINIUM THERAPEUTICS INC | DFTX | Other | 2.09% | 400,000 | +400,000 | +100.00% | $18,816,000 |
| VERACYTE INC | VCYT | Healthcare | 2.08% | 318,001 | +138,301 | +76.96% | $18,676,199 |
| GUARDANT HEALTH INC | GH | Healthcare | 1.67% | 99,826 | +1,312 | +1.33% | $14,976,895 |
| C4 THERAPEUTICS INC | CCCC | Healthcare | 1.58% | 3,032,060 | +1,120,275 | +58.60% | $14,159,720 |
| ZENAS BIOPHARMA INC | ZBIO | Other | 1.44% | 509,789 | -626,146 | -55.12% | $12,938,445 |
| TREVI THERAPEUTICS INC | TRVI | Healthcare | 1.41% | 678,095 | +166,968 | +32.67% | $12,646,472 |
| ALX ONCOLOGY HLDGS INC | ALXO | Healthcare | 1.32% | 5,744,757 | +5,744,757 | +100.00% | $11,891,647 |
| VERADERMICS INC | MANE | Other | 1.30% | 95,000 | +95,000 | +100.00% | $11,679,300 |
| XENON PHARMACEUTICALS INC | XENE | Healthcare | 1.26% | 186,821 | -10,938 | -5.53% | $11,276,516 |
| AVALYN PHARMACEUTICALS INC | AVLN | Other | 1.21% | 330,487 | +330,487 | +100.00% | $10,879,632 |
| BIOGEN INC | BIIB | Healthcare | 1.16% | 48,101 | -2,866 | -5.62% | $10,392,702 |
| ACLARIS THERAPEUTICS INC | ACRS | Healthcare | 1.15% | 1,946,482 | +1,946,482 | +100.00% | $10,296,890 |
| CERUS CORP | CERS | Healthcare | 1.13% | 3,472,737 | +296,190 | +9.32% | $10,140,392 |
| AVALO THERAPEUTICS INC | AVTX | Healthcare | 1.03% | 500,402 | -24,034 | -4.58% | $9,247,429 |
| BENITEC BIOPHARMA INC | BNTC | Healthcare | 1.01% | 679,826 | -37,899 | -5.28% | $9,096,072 |
Showing 30 of 61 holdings in the latest reporting period.